003090.KO Daewoong

Healthcare Pharmaceuticals Korea Stock Exchange
16,640 KRW
Close of Nov 5, 2026
14,380 30,600
Market cap
KRW 699B
P/E
3.8x
P/B
0.54x
ROE
11.1%
Dividend yield
1.80%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 003090.KO undervalued?

Graham number

The Graham number of Daewoong cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Daewoong fundamental analysis

No fundamental analysis for Daewoong yet.

Daewoong stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoon…

Full company profile